Nitrosoureas and beyond: What to do when the CPCA doesn’t apply
Experts David Ponting (Principal Scientist, Lhasa Limited) and Natan Segretti (CSO, Consult Lhasa), delivered an explorative webinar on the recently updated EMA guidelines for nitrosoureas risk assessment. Natan provided a comprehensive overview of this critical regulatory update, explaining why nitrosoureas are classified within the cohort of concern and the reasoning behind these new regulatory […]
Nitrosoureas and beyond: What to do when the CPCA doesn’t apply Read More »